Cubist Systematic Strategies, LLC Abbott Laboratories Transaction History

Cubist Systematic Strategies, LLC

$20.3 Billion
Q2 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 205,900 shares of ABT stock, worth $27.7 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

205,900

Previous 229,300 10.2%

Holding current value

$27.7 Million

Previous $30.4 Million 7.93%

% of portfolio

0.14%

Previous 0.19%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $16.4 Million - $18.1 Million	149,970 New	149,970 $17 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $22.4 Million - $26.9 Million	234,816 New	234,816 $22.7 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $46.5 Million - $54.8 Million	480,243 Added 4680.27%	490,504 $49.7 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $18.6 Million - $21.8 Million	-195,602 Reduced 95.02%	10,261 $1.13 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $23.6 Million - $27.3 Million	-244,018 Reduced 54.24%	205,863 $19.9 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $3.58 Million - $4.33 Million	35,103 Added 8.46%	449,881 $48.9 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $31.8 Million - $38.8 Million	278,953 Added 205.38%	414,778 $49.1 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $2.36 Million - $2.89 Million	20,398 Added 17.67%	135,825 $19.1 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $3.89 Million - $4.31 Million	33,377 Added 40.68%	115,427 $13.6 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $10.9 Million - $12.8 Million	-102,882 Reduced 55.63%	82,050 $9.51 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $13.1 Million - $15.5 Million	120,817 Added 188.44%	184,932 $22.2 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $509,670 - $555,394	-4,854 Reduced 7.04%	64,115 $7.02 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $2.23 Million - $2.7 Million	-24,291 Reduced 26.05%	68,969 $7.51 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $675,423 - $864,458	8,821 Added 10.45%	93,260 $8.53 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $5.1 Million - $7.46 Million	81,212 Added 2516.64%	84,439 $6.66 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $755,972 - $841,574	-9,629 Reduced 74.9%	3,227 $280,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $548,819 - $595,090	6,706 Added 109.04%	12,856 $1.08 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $306,168 - $357,085	4,201 Added 215.55%	6,150 $517,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $129,062 - $156,036	1,949 New	1,949 $156,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $455,707 - $516,250	-6,951 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $2.08 Million - $2.51 Million	-34,272 Reduced 83.14%	6,951 $510,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $1.94 Million - $2.14 Million	-33,723 Reduced 45.0%	41,223 $2.51 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $1.31 Million - $1.49 Million	23,367 Added 45.3%	74,946 $4.49 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $1.76 Million - $1.89 Million	32,814 Added 174.87%	51,579 $2.94 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $901,845 - $1.01 Million	18,765	18,765 $1 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Abbott Laboratories Transaction History